Are you Dr. Nelson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
NE Pacific St
# 1959
Seattle, WA 98195Phone+1 206-288-1000Fax+1 206-520-5620
Summary
- Dr. Peter Nelson, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Texas, and Louisiana. He is affiliated with UW Medicine/University of Washington Medical Center, Fred Hutch Cancer Center, and Mason Health.
Education & Training
- University of WashingtonFellowship, Medical Oncology, 1989 - 1991
- University of Kansas School of MedicineClass of 1986, MD
Certifications & Licensure
- WA State Medical License 1993 - 2025
- LA State Medical License 2007 - 2017
- TX State Medical License 2008 - 2017
- MD State Medical License 1990 - 1993
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression.Sun H Park, Shunsuke Tsuzuki, Kelly F Contino, Jenna Ollodart, Matthew R Eber
Life Science Alliance. 2024-12-01 - 2 citationsProposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group...Jane K Nguyen, Lara R Harik, Eric A Klein, Jianbo Li, Dillon Corrigan
Histopathology. 2024-10-01 - BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.Daniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, Jan Rekowski, Claire Pettinger
The Journal of Clinical Investigation. 2024-09-17
Press Mentions
- Fred Hutch at AACR: New Targets for Cancer Therapies, Experts Available in Diversity and Cancer Screening Tests — and Fred Hutch’s Philip Greenberg Becomes AACR PresidentApril 6th, 2023
- Precision Cancer Drugs Glitter with Promise—if You Can Get ThemNovember 8th, 2023